BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

MEDA 

Meda Pharmaceuticals Inc.
265 Davidson Avenue, Suite 300
Somerset  New Jersey  08873-4120  U.S.A.
Phone: 732-564-2200 Fax: n/a


SEARCH JOBS




Industry
Pharmaceutical






 Company News
MEDA Release: Interim Report, January–March 2013 5/7/2013 8:03:06 AM    More...
Meda AB (MEDA-A.ST): Acquisition of Women's Health Products Completed 10/16/2012 10:22:05 AM    More...
MEDA Release: Acquisition of Women’s Health Products Completed 10/16/2012 9:49:33 AM    More...
MEDA: Zyclara Receives Positive Opinion from the Committee for Human Medicinal Products in the European Union 6/25/2012 10:02:32 AM    More...
EpiCept Corporation (EPCT) Transfers Ceplene Responsibilities in European Union and Sells License Rights to MEDA 6/19/2012 11:02:05 AM    More...
MEDA: Edluar Approved in Europe 6/15/2012 10:12:07 AM    More...
MEDA's Dymista Approved by the FDA 5/2/2012 6:57:59 AM    More...
MEDA: Collaboration with Omega Pharma NV (0OMEP.BR) for SB12 12/9/2011 11:44:59 AM    More...
MEDA Dymista Filed in Europe 10/28/2011 9:05:40 AM    More...
MEDA Responds to Article in the Wall Street Journal 7/27/2011 7:54:58 AM    More...
123